Axonics, Inc. (AXNX): Company Cash Volume

Official company branding of Axonics Modulation Technologies (AXNX)

High margins on neurostimulation systems provide Axonics, Inc. (AXNX) with a powerful capital inflow and market resilience. This enables the company to aggressively attract bioengineers through generous stock option programs. Cost optimization is achieved via contract manufacturing and outsourced logistics management. This cash position chart illustrates the dynamics of liquid assets, where 0.00 forms the current metric value.

Company Cash Funds: Axonics, Inc (AXNX) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Axonics Inc. (AXNX)

- stock quotes and analyst forecast:
Initial company analysis:Axonics, Inc AXNX
Brand item of Axonics

For Axonics, Inc. (AXNX), a steady inflow of capital within the medical innovation sector makes cash reserves a key indicator of financial stability. This metric aggregates all liquid assets and equivalents, measuring the company's real-time ability to cover short-term liabilities. By analyzing the history of cash flow changes, an investor assesses the balance between solvency and investment efficiency. Growing reserves confirm the asset's defensive qualities, ensuring business development regardless of macroeconomic fluctuations.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Company Total Cash Volume|ZJYL - Company Cash Funds|VANI (vivani.com) - Company Cash and Cash Equivalents|XTNT (Xtant Medical Inc) - Company Cash on Hand|Company Cash Reserve n1mtc.com (NMTC)|Company Cash Funds modular-medical.com|Company Cash and Cash Equivalents MYO (Myomo)|Company Cash Volume COCH|VVOS (Vivos Therapeutics, Inc) - Company Cash Balance|Company Cash Funds envveno.com NVNO|SINT - Company Cash on Hand|Tenon Medical Inc. - Company Cash Volume|LFWD: Company Cash Funds|Autonomix (AMIX) - Company Cash Funds|IVF - Company Liquid Assets|BBLG (bonebiologics.com) - Company Cash Volume|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)